クリ・デュ・チャット症候群治療市場:治療法別(理学療法、言語療法、作業療法)、エンドユーザー別(病院、専門クリニック、その他)、地域別(北米、欧州、APAC、RoW)-2027年までの予測Cri-du-chat Syndrome Treatment Market by Treatment (Physiotherapy, Speech Therapy and Occupational Therapy), End User (Hospitals and Specialty Clinics and Others) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Cri-du-chat症候群は成長と発達を阻害し、出生時に明らかになる。この症候群の乳児は、ネコのような甲高い叫び声、小さな頭、特徴的な顔貌を持つことが多い。一般的な徴候は、猫の鳴き声のように聞こえる独特の泣... もっと見る
サマリーCri-du-chat症候群は成長と発達を阻害し、出生時に明らかになる。この症候群の乳児は、ネコのような甲高い叫び声、小さな頭、特徴的な顔貌を持つことが多い。一般的な徴候は、猫の鳴き声のように聞こえる独特の泣き声、特徴的な顔貌、成長の遅れ、小頭症である。世界のCri-Du-Chat症候群治療市場は、推定期間中に重要な成長を目撃すると予測されている。およそ50,000人に1人の赤ちゃんがこのような障害に罹患している。Cri-du-Chat症候群に関連する障害の発生が増加していることは、世界のCri-du-Chat症候群治療市場を促進する可能性が高い主要な側面である。行動療法や発達療法に対する需要の高まりも、市場の成長を促進すると予想される。録画済みビデオ教材やコンピューターまたはビデオ通話などの理学療法のための新しいサービス、それらの急増はさらにクリ・ドゥ・チャット症候群治療市場の機会を煽る。その一方で、治療費の増加、人々の認知度の低さ、遺伝的欠陥の連鎖などは、予測期間中に市場が抑制されると予想される数少ない要因である。Cri-du-chat症候群治療市場は、2027年までに年平均成長率3.6%で成長すると予測される。治療法に基づくクリ・ドゥ・チャット症候群治療市場 - 理学療法 - 言語療法 - 作業療法 エンドユーザー別Cri-du-chat症候群治療市場 - 病院および専門クリニック - その他 Cri-du-chat症候群治療市場:地域別 - 北米 - ヨーロッパ - アジア太平洋 - その他の地域 Cri-du-chat症候群治療市場は、治療法に基づき、理学療法、言語療法、作業療法に分けられます。すべての治療法の中で、理学療法分野が市場で大きなシェアを占めている。この分野の大きなシェアは、理学療法とその利点に関する意識の高まりによるものです。理学療法は、乳幼児期から小児期にかけて、転がったり、歩いたり、走ったり、ジャンプしたりと、クリ・ドゥ・チャット症候群の子どもの筋力を発達させ、粗大運動スキルのマイルストーンを達成するのに役立ちます。 エンドユーザー別に見ると、市場は病院・専門クリニックとその他に二分される。クリ・デュ・チャット症候群治療市場の成長では、病院・専門クリニック分野が大きなシェアを占めている。このセグメントのシェアは、病院が外来患者と入院患者の両方に高いキャパシティを提供しているという事実が占めている。加えて、患者は病院や専門クリニックの方が他の施設よりも優れた治療を受けられると信頼している。一方、その他の分野もかなりの成長率で推移すると思われる。 地域別分析によると、市場は北米、欧州、アジア太平洋地域、その他の地域に分類される。クリ・ドゥ・チャット症候群治療薬市場では、北米地域が最も高いシェアを占めている。これは、理学療法技術の進歩、クリ・ドゥ・チャット症候群の理学療法治療に関する認知度の向上、主要かつ強力な病院インフラがこの地域に存在するためと考えられます。 さらに、世界中の政府が、クリ・ドゥ・チャット症候群を含む希少疾患の研究開発に投資しています。これらのイニシアチブは、研究開発のための資金提供や、製薬会社がクリデュチャット症候群の治療法に投資するためのインセンティブを提供している。このように、研究への取り組みが活発化していることが、Cri-du-chat症候群治療市場の成長を後押ししている。これとは別に、Cri-du-chat症候群の基本的なメカニズムを理解し、新しい治療法や治療法を開発することに重点を置いた研究が増加している。この研究は、世界のCri-du-chat症候群治療市場の技術革新を推進しており、将来的には新たな治療オプションにつながると予測されている。 Hoppers Physio、Movement Masters Physical Therapy、Chatham Speech and Myo、Jeevam Therapy、Institute for Child Development、Physiocomestoyou、Euro-Therapies、Blossoms Physiotherapy、Pediatric Advanced Therapy、Rio Children's Hospitalが、この市場の主要プレイヤーです。 そのため、クリ・デュ・チャット症候群の発症率の増加が、治療に対する大きな需要を生み出している。さらに、人々は症候群についてより意識するようになり、子供の親は、理学療法、言語療法、作業療法などの新興治療が重要な役割を果たしている助けを求めている。 - この調査レポートは、市場ダイナミクスの顕著な変化の詳細と市場のセグメンテーションの詳細を提供しています。 - 本レポートでは、過去、現在、予測市場分析を質的、量的に描写しています。 - また、市場の発展や新興セグメント、地域市場の評価も提供しています。 - 主要ベンダーの重要戦略、合併、企業拡大、買収、新製品発表も本レポートに含まれています。 目次1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Treatment: Market Size & Analysis 5.1. Overview 5.2. Physiotherapy 5.3. Speech Therapy 5.4. Occupational Therapy 6. End User: Market Size & Analysis 6.1. Overview 6.2. Hospitals and Specialty Clinics 6.3. Others 7. Geography: Market Size & Analysis 7.1. Overview 7.2. North America 7.3. Europe 7.4. Asia Pacific 7.5. Rest of the World 8. Competitive Landscape 8.1. Competitor Comparison Analysis 8.2. Market Developments 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 8.2.2. Product Launches and execution 9. Vendor Profiles 9.1. Hoppers Physio 9.1.1. Overview 9.1.2. Financial Overview 9.1.3. Product Offerings 9.1.4. Developments 9.1.5. Business Strategy 9.2. Movement Masters Physical Therapy 9.2.1. Overview 9.2.2. Financial Overview 9.2.3. Product Offerings 9.2.4. Developments 9.2.5. Business Strategy 9.3. Chatham Speech and Myo 9.3.1. Overview 9.3.2. Financial Overview 9.3.3. Product Offerings 9.3.4. Developments 9.3.5. Business Strategy 9.4. Jeevam Therapy 9.4.1. Overview 9.4.2. Financial Overview 9.4.3. Product Offerings 9.4.4. Developments 9.4.5. Business Strategy 9.5. the Institute for Child Development 9.5.1. Overview 9.5.2. Financial Overview 9.5.3. Product Offerings 9.5.4. Developments 9.5.5. Business Strategy 9.6. Physiocomestoyou 9.6.1. Overview 9.6.2. Financial Overview 9.6.3. Product Offerings 9.6.4. Developments 9.6.5. Business Strategy 9.7. Euro-Therapies 9.7.1. Overview 9.7.2. Financial Overview 9.7.3. Product Offerings 9.7.4. Developments 9.7.5. Business Strategy 9.8. Blossoms Physiotherapy 9.8.1. Overview 9.8.2. Financial Overview 9.8.3. Product Offerings 9.8.4. Developments 9.8.5. Business Strategy 9.9. Pediatric Advanced Therapy 9.9.1. Overview 9.9.2. Financial Overview 9.9.3. Product Offerings 9.9.4. Developments 9.9.5. Business Strategy 9.10. Rio Children's Hospital 9.10.1. Overview 9.10.2. Financial Overview 9.10.3. Product Offerings 9.10.4. Developments 9.10.5. Business Strategy 10. Analyst Opinion 11. Annexure 11.1. Report Scope 11.2. Market Definitions 11.3. Research Methodology 11.3.1. Data Collation and In-house Estimation 11.3.2. Market Triangulation 11.3.3. Forecasting 11.4. Report Assumptions 11.5. Declarations 11.6. Stakeholders 11.7. Abbreviations 図表リストTABLE 1. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2026 (USD BILLION)TABLE 2. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR PHYSIOTHERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR SPEECH THERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR OCCUPATIONAL THERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 6. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR HOSPITALS AND SPECIALTY CLINICS, 2021-2027 (USD BILLION) TABLE 7. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 9. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 10. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 11. U.S CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 12. U.S CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 13. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 14. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 15. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 16. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 17. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, END USER, 2021-2027 (USD BILLION) TABLE 18. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 19. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 20. U.K CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 21. U.K CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 22. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 23. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 24. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 25. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 26. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 27. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 28. ROE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 29. ROE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 30. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 31. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 32. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 33. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 34. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 35. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 36. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 37. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 38. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 39. REST OF APAC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 40. REST OF APAC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 41. REST OF WORLD CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 42. REST OF WORLD CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 43. HOPPERS PHYSIO: FINANCIALS TABLE 44. HOPPERS PHYSIO: PRODUCTS & SERVICES TABLE 45. HOPPERS PHYSIO: RECENT DEVELOPMENTS TABLE 46. MOVEMENT MASTERS PHYSICAL THERAPY: FINANCIALS TABLE 47. MOVEMENT MASTERS PHYSICAL THERAPY: PRODUCTS & SERVICES TABLE 48. MOVEMENT MASTERS PHYSICAL THERAPY: RECENT DEVELOPMENTS TABLE 49. CHATHAM SPEECH AND MYO: FINANCIALS TABLE 50. CHATHAM SPEECH AND MYO: PRODUCTS & SERVICES TABLE 51. CHATHAM SPEECH AND MYO: RECENT DEVELOPMENTS TABLE 52. JEEVAM THERAPY: FINANCIALS TABLE 53. JEEVAM THERAPY: PRODUCTS & SERVICES TABLE 54. JEEVAM THERAPY: RECENT DEVELOPMENTS TABLE 55. THE INSTITUTE FOR CHILD DEVELOPMENT: FINANCIALS TABLE 56. THE INSTITUTE FOR CHILD DEVELOPMENT: PRODUCTS & SERVICES TABLE 57. THE INSTITUTE FOR CHILD DEVELOPMENT: RECENT DEVELOPMENTS TABLE 58. PHYSIOCOMESTOYOU: FINANCIALS TABLE 59. PHYSIOCOMESTOYOU: PRODUCTS & SERVICES TABLE 60. PHYSIOCOMESTOYOU: RECENT DEVELOPMENTS TABLE 61. EURO-THERAPIES: FINANCIALS TABLE 62. EURO-THERAPIES: PRODUCTS & SERVICES TABLE 63. EURO-THERAPIES: RECENT DEVELOPMENTS TABLE 64. BLOSSOMS PHYSIOTHERAPY: FINANCIALS TABLE 65. BLOSSOMS PHYSIOTHERAPY: PRODUCTS & SERVICES TABLE 66. BLOSSOMS PHYSIOTHERAPY: RECENT DEVELOPMENTS TABLE 67. PEDIATRIC ADVANCED THERAPY: FINANCIALS TABLE 68. PEDIATRIC ADVANCED THERAPY: PRODUCTS & SERVICES TABLE 69. PEDIATRIC ADVANCED THERAPY: RECENT DEVELOPMENTS TABLE 70. RIO CHILDREN'S HOSPITAL: FINANCIALS TABLE 71. RIO CHILDREN'S HOSPITAL: PRODUCTS & SERVICES TABLE 72. RIO CHILDREN'S HOSPITAL: RECENT DEVELOPMENTS
SummaryCri-du-chat syndrome obstructs the growth and development and is obvious at birth. Infants with this syndrome often have a feline-like scream, high-pitched, a small head, and distinctive facial features. Common signs are a peculiar cry which sounds as a cat meowing, distinctive facial traits, slow growth, and microcephaly, which is featured by a smaller head size than regular would be distinctive for an infant's age and sex. The global Cri-Du-Chat syndrome treatment market is projected to witness vital growth during the estimated period. Around one in every 50,000 babies is affected from these disorders. The increasing occurrence of Cri-du-chat syndrome-associated disorders is a major aspect likely to fuel the worldwide Cri-du-chat syndrome treatment market. Rising demand for behavioral and developmental therapies is also expected to augment the market growth. New services for physical therapy, such as pre-recorded video material and computer or video calls, the surge in them further fuels the cri-du-chat syndrome treatment market opportunity. On the other hand, the increased cost of the treatment and dearth of awareness among people and pre-linked genetic defects are few factors the market is expected to get restrained in the forecast period. The Cri-du-chat Syndrome Treatment Market is anticipated to grow at a rate of 3.6% CAGR by 2027. Table of Contents1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Treatment: Market Size & Analysis 5.1. Overview 5.2. Physiotherapy 5.3. Speech Therapy 5.4. Occupational Therapy 6. End User: Market Size & Analysis 6.1. Overview 6.2. Hospitals and Specialty Clinics 6.3. Others 7. Geography: Market Size & Analysis 7.1. Overview 7.2. North America 7.3. Europe 7.4. Asia Pacific 7.5. Rest of the World 8. Competitive Landscape 8.1. Competitor Comparison Analysis 8.2. Market Developments 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 8.2.2. Product Launches and execution 9. Vendor Profiles 9.1. Hoppers Physio 9.1.1. Overview 9.1.2. Financial Overview 9.1.3. Product Offerings 9.1.4. Developments 9.1.5. Business Strategy 9.2. Movement Masters Physical Therapy 9.2.1. Overview 9.2.2. Financial Overview 9.2.3. Product Offerings 9.2.4. Developments 9.2.5. Business Strategy 9.3. Chatham Speech and Myo 9.3.1. Overview 9.3.2. Financial Overview 9.3.3. Product Offerings 9.3.4. Developments 9.3.5. Business Strategy 9.4. Jeevam Therapy 9.4.1. Overview 9.4.2. Financial Overview 9.4.3. Product Offerings 9.4.4. Developments 9.4.5. Business Strategy 9.5. the Institute for Child Development 9.5.1. Overview 9.5.2. Financial Overview 9.5.3. Product Offerings 9.5.4. Developments 9.5.5. Business Strategy 9.6. Physiocomestoyou 9.6.1. Overview 9.6.2. Financial Overview 9.6.3. Product Offerings 9.6.4. Developments 9.6.5. Business Strategy 9.7. Euro-Therapies 9.7.1. Overview 9.7.2. Financial Overview 9.7.3. Product Offerings 9.7.4. Developments 9.7.5. Business Strategy 9.8. Blossoms Physiotherapy 9.8.1. Overview 9.8.2. Financial Overview 9.8.3. Product Offerings 9.8.4. Developments 9.8.5. Business Strategy 9.9. Pediatric Advanced Therapy 9.9.1. Overview 9.9.2. Financial Overview 9.9.3. Product Offerings 9.9.4. Developments 9.9.5. Business Strategy 9.10. Rio Children's Hospital 9.10.1. Overview 9.10.2. Financial Overview 9.10.3. Product Offerings 9.10.4. Developments 9.10.5. Business Strategy 10. Analyst Opinion 11. Annexure 11.1. Report Scope 11.2. Market Definitions 11.3. Research Methodology 11.3.1. Data Collation and In-house Estimation 11.3.2. Market Triangulation 11.3.3. Forecasting 11.4. Report Assumptions 11.5. Declarations 11.6. Stakeholders 11.7. Abbreviations List of Tables/GraphsTABLE 1. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2026 (USD BILLION)TABLE 2. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR PHYSIOTHERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR SPEECH THERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR OCCUPATIONAL THERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 6. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR HOSPITALS AND SPECIALTY CLINICS, 2021-2027 (USD BILLION) TABLE 7. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 9. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 10. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 11. U.S CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 12. U.S CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 13. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 14. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 15. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 16. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 17. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, END USER, 2021-2027 (USD BILLION) TABLE 18. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 19. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 20. U.K CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 21. U.K CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 22. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 23. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 24. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 25. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 26. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 27. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 28. ROE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 29. ROE CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 30. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 31. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 32. ASIA PACIFC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 33. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 34. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 35. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 36. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 37. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 38. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 39. REST OF APAC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 40. REST OF APAC CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 41. REST OF WORLD CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION) TABLE 42. REST OF WORLD CRI-DU-CHAT SYNDROME TREATMENT MARKET VALUE, BY END USER, 2021-2027 (USD BILLION) TABLE 43. HOPPERS PHYSIO: FINANCIALS TABLE 44. HOPPERS PHYSIO: PRODUCTS & SERVICES TABLE 45. HOPPERS PHYSIO: RECENT DEVELOPMENTS TABLE 46. MOVEMENT MASTERS PHYSICAL THERAPY: FINANCIALS TABLE 47. MOVEMENT MASTERS PHYSICAL THERAPY: PRODUCTS & SERVICES TABLE 48. MOVEMENT MASTERS PHYSICAL THERAPY: RECENT DEVELOPMENTS TABLE 49. CHATHAM SPEECH AND MYO: FINANCIALS TABLE 50. CHATHAM SPEECH AND MYO: PRODUCTS & SERVICES TABLE 51. CHATHAM SPEECH AND MYO: RECENT DEVELOPMENTS TABLE 52. JEEVAM THERAPY: FINANCIALS TABLE 53. JEEVAM THERAPY: PRODUCTS & SERVICES TABLE 54. JEEVAM THERAPY: RECENT DEVELOPMENTS TABLE 55. THE INSTITUTE FOR CHILD DEVELOPMENT: FINANCIALS TABLE 56. THE INSTITUTE FOR CHILD DEVELOPMENT: PRODUCTS & SERVICES TABLE 57. THE INSTITUTE FOR CHILD DEVELOPMENT: RECENT DEVELOPMENTS TABLE 58. PHYSIOCOMESTOYOU: FINANCIALS TABLE 59. PHYSIOCOMESTOYOU: PRODUCTS & SERVICES TABLE 60. PHYSIOCOMESTOYOU: RECENT DEVELOPMENTS TABLE 61. EURO-THERAPIES: FINANCIALS TABLE 62. EURO-THERAPIES: PRODUCTS & SERVICES TABLE 63. EURO-THERAPIES: RECENT DEVELOPMENTS TABLE 64. BLOSSOMS PHYSIOTHERAPY: FINANCIALS TABLE 65. BLOSSOMS PHYSIOTHERAPY: PRODUCTS & SERVICES TABLE 66. BLOSSOMS PHYSIOTHERAPY: RECENT DEVELOPMENTS TABLE 67. PEDIATRIC ADVANCED THERAPY: FINANCIALS TABLE 68. PEDIATRIC ADVANCED THERAPY: PRODUCTS & SERVICES TABLE 69. PEDIATRIC ADVANCED THERAPY: RECENT DEVELOPMENTS TABLE 70. RIO CHILDREN'S HOSPITAL: FINANCIALS TABLE 71. RIO CHILDREN'S HOSPITAL: PRODUCTS & SERVICES TABLE 72. RIO CHILDREN'S HOSPITAL: RECENT DEVELOPMENTS
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポートIHR Insights社の医療分野での最新刊レポート
本レポートと同じKEY WORD(end user)の最新刊レポート
よくあるご質問IHR Insights社はどのような調査会社ですか?IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |